Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | retinoblastoma binding protein | 0.0145 | 0.0427 | 0.0427 |
Schistosoma mansoni | hypothetical protein | 0.1517 | 1 | 1 |
Trichomonas vaginalis | WD repeat domain, putative | 0.1517 | 1 | 1 |
Echinococcus multilocularis | wd40 repeat | 0.0145 | 0.0427 | 0.0427 |
Echinococcus granulosus | protein will die slowly | 0.1517 | 1 | 1 |
Echinococcus multilocularis | protein will die slowly | 0.1517 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0084 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0145 | 0.0427 | 0.0427 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.0427 | 0.0427 |
Echinococcus granulosus | wd40 repeat | 0.0145 | 0.0427 | 0.0427 |
Onchocerca volvulus | 0.1517 | 1 | 0.5 | |
Plasmodium falciparum | SPRY domain, putative | 0.0084 | 0 | 0.5 |
Trichomonas vaginalis | retinoblastoma binding protein, putative | 0.0145 | 0.0427 | 0.0427 |
Brugia malayi | Hypothetical WD-repeat protein F21H12.1 in chromosome II | 0.0145 | 0.0427 | 0.0427 |
Loa Loa (eye worm) | WD40 repeat protein | 0.1517 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.